Eli Lilly Invests $1.8B To Expand Drug Output in Ireland

Key TakeawaysEli Lilly is investing $1.8 billion to expand production in Ireland of its Alzheimer's treatment and weight-loss drugs.The company's Alzheimer's drug, Kisunla, was approved by the U.S. Food and Drug Administration last month.Eli Lilly has committed more than $20 billion to manufacturing investments in the U.S. and Europe since 2020. Eli Lilly (LLY) said Thursday it will spend $1.8 billion to expand production in Ireland of its popular diabetes and weight-loss drugs, as well as some active ingre ...